Hollis L. Albright, MD ’31 Symposium

Top menu

About HMS

More... Share to Twitter Share to Facebook
Hollis L. Albright, MD ’31 Symposium

RSVP for the 2018 symposium

Transformative Discoveries in Cancer Immunotherapy

Thursday, March 29 // 5:00 p.m.

New Research Building
77 Avenue Louis Pasteur
Boston, MA 02115
Doors open at 4:30 p.m.
Reception to follow

RSVP today »

Arlene Sharpe

Arlene H. Sharpe, AB ’75, AM ’76, PhD ’81, MD ’82
George Fabyan Professor of Comparative Pathology, HMS and Co-Director, Evergrande Center for Immunologic Diseases, HMS and Brigham and Women's Hospital

Steven Rosenberg

Steven A. Rosenberg, MD, PhD ’69
Chief of Surgery, National Cancer Institute

Tenley Albright

Tenley E. Albright, MD ’61

Highlighting: "What's New at Harvard Medical School?"
George Daley

George Q. Daley, AB ’82, MD ’91, PhD
Dean, Harvard Medical School

Presentation of the 2018 Albright Scholar Award
Jennifer Bido, MPH ’17, HMS 2018 

For more information, please email Allie Keeler at albright@hms.harvard.edu.

Speaker Biographies

George Q. Daley is the 22nd dean of Harvard Medical School and the Caroline Shields Walker Professor of Medicine. An internationally recognized leader in stem cell science and cancer biology, his work spans the fields of basic science and clinical medicine. Daley’s lab aims to define fundamental principles of how stem cells contribute to tissue regeneration and repair and improve drug and transplantation therapies for patients with malignant and genetic bone marrow disease. Beyond his research, he has helped to lead the development of international guidelines for conducting stem cell research and for the clinical translation of stem cells.

Arlene Sharpe is the George Fabyan Professor of Comparative Pathology at Harvard Medical School and co-director of the Evergrande Center for Immunologic Diseases at HMS and Brigham and Women’s Hospital. She is a leader in the field of T cell costimulation. Her laboratory has discovered and elucidated the functions of T cell costimulatory pathways, including the immunoinhibitory functions of the CTLA-4 and PD-1 pathways, which have become exceptionally promising targets for cancer immunotherapy. Her laboratory currently focuses on the roles of T cell costimulatory pathways in regulating T cell tolerance and effective antimicrobial and antitumor immunity and translating fundamental understanding of T cell costimulation into new therapies for autoimmune diseases and cancer.

Steven Rosenberg is chief of surgery at the National Cancer Institute in Bethesda, Maryland, and a professor of surgery at the Uniformed Services University of Health Sciences and the George Washington University School of Medicine and Health Sciences. He developed the first effective immunotherapies and gene therapies for patients with advanced cancer. His studies of cell transfer immunotherapy have resulted in durable complete remissions in patients with metastatic melanoma. He was the first to successfully insert foreign genes into humans, and his recent studies of the adoptive transfer of genetically modified lymphocytes have resulted in the regression of metastatic cancer in patients with melanoma, sarcomas, and lymphomas.

Hollis L.


Hollis L. Albright

For more than 60 years, Hollis L. Albright, MD ’31, dedicated his life to surgery, patient care, and the students he mentored.

In recognition of his lifelong achievements and to foster the values he cherished most, his children—Tenley E. Albright, MD ’61, and Nile L. Albright, AB ’61, MD—have established an endowed symposium, highlighting new scientific initiatives at Harvard Medical School.


In addition, the Hollis L. Albright, MD ’31 Award is presented at the annual symposium to an outstanding medical or surgical student at Harvard Medical School.

Past Keynote Speakers

2017: David M. Altshuler, MD ’90, PhD ’90, and Laurie H. Glimcher, AB ’72, MD ’76
2016: Dennis A. Ausiello, AM  ’67, MD, and Nancy E. Oriol, MD ’79
2015: Edward M. Hundert, MD ’84, and George Q. Daley, AB ’82, MD ’91, PhD
2013: Lewis C. Cantley, PhD and Peter K. Sorger, AB ’83, PhD
2012: Elizabeth G. Nabel, MD, and John A. Parrish, MD
2011: Eric S. Lander, PhD, and Vamsi K. Mootha, MD ’98
2010: Robert S. Langer Jr., PhD, ScD, and David T. Scadden, MD
2009: Edward J. Benz Jr., MD ’72, and Robert A. Weinberg, PhD
2008: Atul A. Gawande, MD ’94, MPH ’99, Tom J. Brady, MD, and John E. Abele
2007: Peter Libby, MD, and Michael B. Brenner, MD
2006: Judah M. Folkman, MD ’57, and Robert S. Langer Jr., PhD, ScD
2005: Edward M. Scolnick, MD ’65, and Todd R. Golub, MD
2004: George Q. Daley, AB ’82, MD ’91, PhD, David T. Scadden, MD, and Rudolf Jaenisch, MD
2003: Gary J. Nabel, MD ’79, PhD ’82
2002: Steven E. Hyman, MD ’80, and Carla J. Shatz, PhD ’76, MPhil
2001: Eric S. Lander, PhD, and Raju Kucherlapati, MD, PhD

Past Scholar Recipients

2017: Irene Y. Zhang, MD ’17
2016: Derek S. Stenquist, MD 16
2015: Shakina Elmore, MD ’14
2013: Sophia K. McKinley, AB ’06, EdM ’13, MD ’13
2012: Benedict U. Nwachukwu, MBA ’13, MD ’13
2011: Dayron Rodriguez, MD ’12, MPH ’12
2010: Regan Bergmark, MD ’11
2009: Carolyn Schook, MD ’11
2008: Theodore Nyame, MD ’09
2007: Eric Feins, MD ’08
2006: Sarah Psutka, AB ’03, MD ’07
2005: Dzifa Kpodzo, MD ’05, MPH ’06
2004: Elisabeth Tomlinson Tracy, AB ’99, MD ’05
2003: Coleen Sabatini, MD ’03, MPH ’04
2002: Jeffrey Edwards, MD ’03
2001: Melody Hou, MD ’03, MPH ’08